The Recall Desk
ModerateFDA (Drugs)·D-1361-2020·Announced 2020-07-08

Children's Robitussin DM Recalled for Missing Dosing Cup Graduations

Glaxosmithkline is recalling 132,336 bottles of Children's Robitussin DM because the included dosing cups lack age-specific measurement markings.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a dosing device defect that could lead to incorrect medication administration, fitting the criteria for moderate severity without reported injuries.

Plain-English summary

Glaxosmithkline Consumer Healthcare Holdings is recalling 132,336 bottles of Children's Robitussin Honey Cough and Chest Congestion DM. The product is a 4 FL OZ (118 mL) oral liquid containing dextromethorphan and guaifenesin, distributed by Pfizer in Madison, NJ. The affected bottles are identified by Lot #s 02177 and 02178, with an expiration date of 01/31/2022, and were distributed nationwide in the US.

The recall was initiated because the dosing cups included with the product are missing graduations applicable to certain age groups. This defect in the delivery system may prevent caregivers from accurately measuring the intended dose for specific age ranges.

Consumers with this product should stop using it and contact the manufacturer or their healthcare provider for guidance on proper dosing or a replacement.

The recalled product

Product
CHILDRENS ROBITUSSIN HONEY COUGH AND CHEST CONGESTION DM (DEXTROMETHORPHAN HBR, GUAIFENESIN)
Brand
CHILDRENS ROBITUSSIN HONEY COUGH AND CHEST CONGESTION DM
Manufacturer
Glaxosmithkline Consumer Healthcare Holdings
Category
Drug — OTC Cough and Cold
Hazard
Affected units
132,336

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (3)

  • Lot #s: 02177
  • 02178
  • Exp. 01/31/2022

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 2 recalled by Glaxosmithkline Consumer Healthcare Holdings under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 2 products in this recall →

Related recalls

Same manufacturer · Glaxosmithkline Consumer Healthcare Holdings

See all →

Same hazard · dosing error

See all →